1.
Front Immunol
; 15: 1361277, 2024.
Article
En
| MEDLINE
| ID: mdl-38711522
In the late stages of the COVID-19 pandemic, there's an increasing trend in opportunistic infections, including bacterial and fungal infections. This study discusses the treatment process of two cases of cryptococcal meningitis during the COVID-19 pandemic. It highlights the importance of laboratory testing for these co-infections and stresses the need for vigilance, early diagnosis, and proactive treatment to improve patient outcomes in the post-pandemic era.
Antifungal Agents , COVID-19 , Meningitis, Cryptococcal , SARS-CoV-2 , Humans , Meningitis, Cryptococcal/drug therapy , Meningitis, Cryptococcal/diagnosis , COVID-19/complications , COVID-19/epidemiology , Male , Antifungal Agents/therapeutic use , Middle Aged , Female , Coinfection , Adult , Cryptococcus neoformans/isolation & purification , Treatment Outcome